Evidence map›Paper›PMID 19865076›Full record

Trial reportNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2010

Effects of treatment for tobacco dependence on resting cerebral glucose metabolism.

Matthew R Costello, Mark A Mandelkern, Stephen Shoptaw, Stephanie Shulenberger, Stephanie K Baker, Anna L Abrams, Catherine Xia, Edythe D London, Arthur L Brody

Open access · bronzeAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Comparing the Effects of Bupropion and Escitalopram on Excessive Internet Game Play in Patients with Major Depressive Disorder.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2017
    Article
  9. Article
  10. Neuroimaging the Effectiveness of Substance Use Disorder Treatments.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2016
    Review
  11. Review
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Matthew R CostelloGreater Los Angeles Veterans Administration Healthcare System, Los Angeles, CA 90095, USA. abrody@ucla.edu
Mark A Mandelkern
Stephen Shoptaw
Stephanie Shulenberger
Stephanie K Baker
Anna L Abrams
Catherine Xia
Edythe D London
Arthur L Brody
VA Greater Los Angeles Healthcare System · USNeurobehavioral Systems · USUniversity of California, Los Angeles · US

Funding

Nicotine Receptor Density & Dopamine System Function in Smokers: Treatment EffectR01DA020872 · NIDA · BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE · PI BRODY, ARTHUR · 2005 to 2013
$2.0M
Treatments for Nicotine Dependence: Brain MechanismsR01DA015059 · NIDA · BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE · PI BRODY, ARTHUR · 2002 to 2005
$1.5M
NIDA NIH HHS R01 DA015059NIDA NIH HHS R01 DA020872
6 · The paper itself

Abstract

While bupropion HCl and practical group counseling (PGC) are commonly used treatments for tobacco dependence, the effects of these treatments on brain function are not well established. For this study, 54 tobacco-dependent cigarette smokers underwent resting (18)F-fluorodeoxyglucose-positron emission tomography (FDG-PET) scanning before and after 8 weeks of treatment with bupropion HCl, PGC, or pill placebo. Using Statistical Parametric Mapping (SPM 2), changes in cerebral glucose metabolism from before to after treatment were compared between treatment groups and correlations were determined between amount of daily cigarette usage and cerebral glucose metabolism. Compared with placebo, the two active treatments (bupropion HCl and PGC) had reductions in glucose metabolism in the posterior cingulate gyrus. Further analysis suggested that PGC had a greater effect than bupropion HCl on glucose metabolism in this region. We also found positive correlations between daily cigarette use and glucose metabolism in the left occipital gyrus and parietal-temporal junction. There were no significant negative correlations between daily cigarette use and glucose metabolism. Our findings suggest that bupropion HCl and PGC reduce neural activity much as the performance of a goal-oriented task does in the default mode network of the brain, including the posterior cingulate gyrus. Thus, this study supports the theory that active treatments for tobacco dependence move the brain into a more goal-oriented state.

Indexed as

AdultBrainBupropionFemaleFluorodeoxyglucose F18GlucoseHumansMaleMiddle AgedPositron-Emission TomographyPsychotherapy, GroupTobacco Use DisorderBupropionFluorodeoxyglucose F18Glucose

Identifiers

PMID19865076
PMCPMC2813904
OpenAlexW2006270680

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.